Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Efficacy of Two Doses of Onabotulinum Toxin for the Treatment of Neurogenic Detrusor Overactivity - a Retrospective Cohort Study

NCT03388086 is registered in ClinicalTrials.gov with Swiss Paraplegic Research, Nottwil as lead sponsor.

NCT NCT03388086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03388086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Efficacy of Two Doses of Onabotulinum Toxin for the Treatment of Neurogenic Detrusor Overactivity - a Retrospective Cohort Study
Lead sponsor
Swiss Paraplegic Research, Nottwil
Phase
Observational
Overall status
Completed
Start date
February 1, 2018
Completion date
July 31, 2019
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurogenic bladder, overactive detrusor